全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

Foveal atrophy and macular hole formation following intravitreal ranibizumab with/without photodynamic therapy for choroidal neovascularization secondary to age-related macular degeneration

Foveal atrophy and macular hole formation following intravitreal ranibizumab with/without photodynamic therapy for choroidal neovascularization secondary to age-related macular degeneration

Retinal ganglion cell function after repeated intravitreal injections of ranibizumab in patients with age-related macular degeneration

Retinal ganglion cell function after repeated intravitreal injections of ranibizumab in patients with age-related macular degeneration

Visual Performance in Patients with Neovascular Age-Related Macular Degeneration Undergoing Treatment with Intravitreal Ranibizumab

A prospective pilot study comparing combined intravitreal ranibizumab and half-fluence photodynamic therapy with ranibizumab monotherapy in the treatment of neovascular age-related macular degeneration

Prophylaxis of Macular Edema with Intravitreal Ranibizumab in Patients with Diabetic Retinopathy after Cataract Surgery: A Pilot Study

Prophylaxis of Macular Edema with Intravitreal Ranibizumab in Patients with Diabetic Retinopathy after Cataract Surgery: A Pilot Study

Intravitreal ranibizumab for symptomatic drusenoid pigment epithelial detachment without choroidal neovascularization in age-related macular degeneration

Intravitreal ranibizumab for symptomatic drusenoid pigment epithelial detachment without choroidal neovascularization in age-related macular degeneration

更多...

Intravitreal injection of ranibizumab for foveal-macular pattern dystrophy: case report

DOI: 10.1590/S0004-27492011000400013

Keywords: fovea centralis, lutein, retinal pigments, tomography, optical coherence, macula lutea, macular degeneration, fluorescein angiography, choroidal neovascularization, antibodies, monoclonal [therapeutic use], intravitreal injections.

Full-Text   Cite this paper   Add to My Lib

Abstract:

in the recent years, anti-angiogenic medications have successfully treated other diseases associated with choroidal neovascularization. the anti-angiogenic therapy alone or combined with laser and/or steroids has been effective in controlling ocular neovascularization, not only restricted to the treatment of typical membranes due to macular degeneration in the wet form. the discovery and subsequent use of these drugs has revolutionized medicine and ophthalmology. this report illustrates an example of successful treatment in a challenging pathology where it was found important visual and anatomical response after the use of ranibizumab.

Full-Text

comments powered by Disqus